MIR378G

Across TCGA pan-cancer cohorts, MIR378G RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR378G’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR378G RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR378G is over-expressed in tumor.

STAD, KICH, and BRCA are the cancer types where MIR378G tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR378G RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.624	.009	4	view →
KICH	All	II,III,IV	+0.452	.006	4	view →
BRCA	All	III,IV	+0.385	.012	2	view →
LUAD	Male	All	+0.734	.034	1	view →
LUSC	Male	II,III,IV	+0.441	.021	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR378G–STAD

Open the STAD breakdown →